Celularity (CELU) Change in Inventory (2020 - 2025)
Celularity (CELU) posted quarterly Change in Inventory of -$1.7 million for Q4 2025, down 173.38% year-over-year from $2.4 million in Q4 2024, and up 25.23% quarter-over-quarter from -$2.3 million in Q3 2025.
Celularity (CELU) Change in Inventory (2020 - 2025) Analysis & Trends
Celularity (CELU) has reported Change in Inventory for 6 consecutive years, with -$1.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Change in Inventory fell 173.38% year-over-year to -$1.7 million; the TTM figure through Dec 2025 stood at -$10.2 million (down 63.05% YoY), while the FY2025 annual figure was -$10.2 million, down 63.05% from the prior year.
- Change in Inventory advanced to -$1.7 million in Q4 2025 per CELU's latest filing, from -$2.3 million in the prior quarter.
- Across five years, Change in Inventory topped out at $9.0 million in Q2 2022 and bottomed at -$3.7 million in Q2 2025.
- Historically, Change in Inventory has averaged $382400.0 across 5 years, with a median of -$221000.0 in 2022.
- Annual changes were most pronounced in 2021 — Change in Inventory jumped 2692.16% — and 2023, when it tumbled 1313.11%.
- Celularity's Change in Inventory stood at $2.6 million in 2021, then sank by 97.69% to $61000.0 in 2022, then sank by 1313.11% to -$740000.0 in 2023, then advanced by 14.73% to -$631000.0 in 2024, then plunged by 173.38% to -$1.7 million in 2025.
- Business Quant data shows CELU's Change in Inventory at -$1.7 million in Q4 2025, -$2.3 million in Q3 2025, and -$3.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Celularity | 20.99 Mn | 14.82 Mn | -3.27 Mn | -1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.73 Mn |
| Dec 31, 2025 | -1.73 Mn |
| Sep 30, 2025 | -2.31 Mn |
| Sep 30, 2025 | -2.31 Mn |
| Jun 30, 2025 | -3.66 Mn |
| Jun 30, 2025 | -3.66 Mn |
| Mar 31, 2025 | -2.55 Mn |
| Mar 31, 2025 | -2.55 Mn |
| Dec 31, 2024 | -631,000.00 |
| Dec 31, 2024 | -631,000.00 |
| Sep 30, 2024 | -503,000.00 |
| Sep 30, 2024 | -503,000.00 |
| Jun 30, 2024 | -1.97 Mn |
| Jun 30, 2024 | -1.97 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Dec 31, 2023 | -740,000.00 |
| Dec 31, 2023 | -740,000.00 |
| Sep 30, 2023 | -1.22 Mn |
| Sep 30, 2023 | -1.22 Mn |